Pharmacogenomics in clinical therapeutics / (Record no. 19163)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 03609cam a2200481Ka 4500 |
001 - CONTROL NUMBER | |
control field | ocn779616174 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20220701010842.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION | |
fixed length control field | m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cn||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 120309s2012 nju ob 001 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | DG1 |
Language of cataloging | eng |
Transcribing agency | DG1 |
Modifying agency | TXA |
-- | YDXCP |
-- | OCLCQ |
-- | OCLCA |
-- | GWM |
-- | OCLCQ |
-- | OCLCF |
-- | OCLCQ |
-- | DG1 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9781119959601 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 1119959608 |
Qualifying information | (electronic bk.) |
029 1# - (OCLC) | |
OCLC library identifier | AU@ |
System control number | 000049013993 |
029 1# - (OCLC) | |
OCLC library identifier | GBVCP |
System control number | 790036355 |
029 1# - (OCLC) | |
OCLC library identifier | NZ1 |
System control number | 15900691 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)779616174 |
037 ## - SOURCE OF ACQUISITION | |
Stock number | 10.1002/9781119959601 |
Source of stock number/acquisition | Wiley InterScience |
Note | http://www3.interscience.wiley.com |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RM301.3.G45 |
Item number | P4235 2012 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.7 |
Edition number | 22 |
049 ## - LOCAL HOLDINGS (OCLC) | |
Holding library | MAIN |
245 00 - TITLE STATEMENT | |
Title | Pharmacogenomics in clinical therapeutics / |
Statement of responsibility, etc | edited by Loralie J. Langman and Amitava Dasgupta. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc | Hoboken : |
Name of publisher, distributor, etc | John Wiley & Sons, |
Date of publication, distribution, etc | 2012. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (ix, 244 pages) |
336 ## - | |
-- | text |
-- | txt |
-- | rdacontent |
337 ## - | |
-- | computer |
-- | c |
-- | rdamedia |
338 ## - | |
-- | online resource |
-- | cr |
-- | rdacarrier |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Front Matter -- Pharmacogenomics Principles: Introduction to Personalized Medicine / Parvaz Madadi, Gideon Koren -- Traditional Therapeutic Drug Monitoring and Pharmacogenomics: Are They Complementary? / Christine L H Snozek, Loralie J Langman, Amitava Dasgupta -- Pharmacogenomics Aspect of Warfarin Therapy / Matthew D Krasowski -- Pharmacogenetics and Cancer Chemotherapy / Christine L H Snozek -- Pharmacogenomic Considerations in Anesthesia and Pain Management / Christine M Formea, Wayne T Nicholson -- Pharmacogenomics of Immunosuppressants / Nicolas Picard, Pierre Marquet -- Pharmacogenomics of Cardiovascular Drugs / Linnea M Baudhuin -- Pharmacogenomic Aspects of Antiretroviral Therapy / Natella Y Rakhmanina, John N van den Anker -- Pharmacogenetics of Psychoactive Drugs / Jorge L Sepulveda -- Pharmacogenomic Aspects of Adverse Drug-Drug Interactions / Loralie J Langman, Christine L H Snozek -- Microarray Technology and Other Methods in Pharmacogenomics Testing / Jorge L Sepulveda -- Pharmacogenetic Testing in the Clinical Laboratory Environment / Mark P Borgman, Mark W Linder -- Index. |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references and index. |
520 ## - SUMMARY, ETC. | |
Summary, etc | Pharmacogenomics is the process of analyzing patients' genes to predict the onset of adverse reactions or forecast the effectiveness of therapeutic drugs. This useful text is written to discuss both the theory and the clinical application of the principles of pharmacogenomics. Current research has clearly established that a range of treatments may be greatly improved through genetic profiling of individual patients before certain therapies begin. Aimed at clinicians, pharmacologists, and clinical laboratory professionals this book discusses the important role of laboratory tests in the practice of personalized medicine. An important new book, Pharmacogenomics in Clinical Therapeutics serves as a guide to the basic principles of pharmacogenomics in a range of common therapeutic areas and as the basis of the personalized medicine of the future. |
588 0# - | |
-- | Print version record. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Pharmacogenetics. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Chemotherapy. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Chemotherapy. |
Source of heading or term | fast |
-- | (OCoLC)fst00853595 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Pharmacogenetics. |
Source of heading or term | fast |
-- | (OCoLC)fst01060243 |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Langman, Loralie J. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dasgupta, Amitava, |
Dates associated with a name | 1958- |
710 2# - ADDED ENTRY--CORPORATE NAME | |
Corporate name or jurisdiction name as entry element | Wiley InterScience (Online service) |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="http://dx.doi.org/10.1002/9781119959601">http://dx.doi.org/10.1002/9781119959601</a> |
Public note | Wiley Online Library |
994 ## - | |
-- | 92 |
-- | DG1 |
No items available.